论文信息 - Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE) - 字舞流文

Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

H. Kantarjian | G. Garcia-Manero | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | N. Pemmaraju | N. Short | M. Ohanian | Allison M. Pike | A. Bidikian | G. Issa | M. Yilmaz | Branko Cuglievan | Miriam B Garcia | Amber Gibson | Michael Andreeff | David McCall | Cesar Nunez | Michael Roth | Sheila Tan | Brianna Kammerer | Cesar Nuñez